Which of the following organizations provides instructions for the storage and handling of vaccines?(1 Point)The Environmental Protection Agency (EPA)The Public Health Service (PHS)The United States Pharmacopeia (USP)The Centers for Disease Control and Prevention (CDC)The Center for Biologics Evaluation and Research (CBER)Molded lozenges are referred to as:(1 Point)TrochesPastillesextractsall of the thesenone of theseWhich of the following is the purpose of adding human albumin to intravenous solutions of sargramostim?(1 Point)Inhibit oxidation of the drugPrevent drug-induced blood clotsStrengthen the conformation of sargramostimServe as a cryoprotectantPrevent drug adsorption onto container and tubing surfacesCharacteristics of gels, EXCEPT(1 Point)SwellingImbibitionThixotropySyneresisNone of theseMost biotechnology peptide and protein drugs must not be strongly agitated or shaken when prepared as solutions for injection because strong agitation can cause:(1 Point)the drugs to adhere to vial and stopper surfaces.aggregation and denaturation.decrease absorption of drug.foaming that prevents observing total dissolution.increase viscosity and impede flow through needles.
Question
Which of the following organizations provides instructions for the storage and handling of vaccines?(1 Point)The Environmental Protection Agency (EPA)The Public Health Service (PHS)The United States Pharmacopeia (USP)The Centers for Disease Control and Prevention (CDC)The Center for Biologics Evaluation and Research (CBER)Molded lozenges are referred to as:(1 Point)TrochesPastillesextractsall of the thesenone of theseWhich of the following is the purpose of adding human albumin to intravenous solutions of sargramostim?(1 Point)Inhibit oxidation of the drugPrevent drug-induced blood clotsStrengthen the conformation of sargramostimServe as a cryoprotectantPrevent drug adsorption onto container and tubing surfacesCharacteristics of gels, EXCEPT(1 Point)SwellingImbibitionThixotropySyneresisNone of theseMost biotechnology peptide and protein drugs must not be strongly agitated or shaken when prepared as solutions for injection because strong agitation can cause:(1 Point)the drugs to adhere to vial and stopper surfaces.aggregation and denaturation.decrease absorption of drug.foaming that prevents observing total dissolution.increase viscosity and impede flow through needles.
Solution
-
The organization that provides instructions for the storage and handling of vaccines is The Centers for Disease Control and Prevention (CDC).
-
Molded lozenges are referred to as Troches.
-
The purpose of adding human albumin to intravenous solutions of sargramostim is to prevent drug adsorption onto container and tubing surfaces.
-
The characteristic that is not a feature of gels is Imbibition.
-
Most biotechnology peptide and protein drugs must not be strongly agitated or shaken when prepared as solutions for injection because strong agitation can cause aggregation and denaturation.
Similar Questions
Complete the table with a short description of what the vaccine consists of.
Which BBP has a vaccine readily available for employees to obtain as a preventative measure before exposure?Hepatitis B Virus (HBV)Hepatitis C Virus (HCV)Human Immunodeficiency Virus (HIV)Herpes Simplex Virus (HSV)
What are made in response to the vaccine?
In which action area of the Ottawa Charter does the Pharmaceutical Benefits Scheme (PBS) belong?
The purpose of vaccine forecasting is
Upgrade your grade with Knowee
Get personalized homework help. Review tough concepts in more detail, or go deeper into your topic by exploring other relevant questions.